figtree know the aussie market well, page-4

Redfaces - SRX which you said you liked the other day has never partnered up with anyone, has not completed phase 3 trials, has borne the burden of a substantial seller for years, has battled multiple court cases, and whilst it extends lives it almost never cures patients completely of their cancer . Still it operates independently and profitibly .

I really don't think you can presume that PRR won't succeed just because it doesn't have a pharma partner yet . I find it very significant that an ex senior Pfizer employee is working with PRR and I don't think that should be discounted .
What are the options for Ovarian Cancer patients ?